These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 19428572)
1. A model for testing the immunogenicity of simian immunodeficiency virus and simian-human immunodeficiency virus vaccine candidates in mice. Xu J; Kelly M; Denning W; Hel Z J Virol Methods; 2009 Jun; 158(1-2):70-6. PubMed ID: 19428572 [TBL] [Abstract][Full Text] [Related]
2. Vaccination of Macaques with DNA Followed by Adenoviral Vectors Encoding Simian Immunodeficiency Virus (SIV) Gag Alone Delays Infection by Repeated Mucosal Challenge with SIV. Almond N; Berry N; Stebbings R; Preston M; Ham C; Page M; Ferguson D; Rose N; Li B; Mee ET; Hassall M; Stahl-Hennig C; Athanasopoulos T; Papagatsias T; Herath S; Benlahrech A; Dickson G; Meiser A; Patterson S J Virol; 2019 Nov; 93(21):. PubMed ID: 31413132 [TBL] [Abstract][Full Text] [Related]
3. DNA Prime-Boost Vaccine Regimen To Increase Breadth, Magnitude, and Cytotoxicity of the Cellular Immune Responses to Subdominant Gag Epitopes of Simian Immunodeficiency Virus and HIV. Hu X; Valentin A; Dayton F; Kulkarni V; Alicea C; Rosati M; Chowdhury B; Gautam R; Broderick KE; Sardesai NY; Martin MA; Mullins JI; Pavlakis GN; Felber BK J Immunol; 2016 Nov; 197(10):3999-4013. PubMed ID: 27733554 [TBL] [Abstract][Full Text] [Related]
4. Gag and env conserved element CE DNA vaccines elicit broad cytotoxic T cell responses targeting subdominant epitopes of HIV and SIV Able to recognize virus-infected cells in macaques. Hu X; Lu Z; Valentin A; Rosati M; Broderick KE; Sardesai NY; Marx PA; Mullins JI; Pavlakis GN; Felber BK Hum Vaccin Immunother; 2018; 14(9):2163-2177. PubMed ID: 29939820 [TBL] [Abstract][Full Text] [Related]
5. Novel simian immunodeficiency virus CTL epitopes restricted by MHC class I molecule Mamu-B*01 are highly conserved for long term in DNA/MVA-vaccinated, SHIV-challenged rhesus macaques. Su J; Luscher MA; Xiong Y; Rustam T; Amara RR; Rakasz E; Robinson HL; MacDonald KS Int Immunol; 2005 May; 17(5):637-48. PubMed ID: 15824066 [TBL] [Abstract][Full Text] [Related]
6. Simian immunodeficiency virus (SIV) gag DNA-vaccinated rhesus monkeys develop secondary cytotoxic T-lymphocyte responses and control viral replication after pathogenic SIV infection. Egan MA; Charini WA; Kuroda MJ; Schmitz JE; Racz P; Tenner-Racz K; Manson K; Wyand M; Lifton MA; Nickerson CE; Fu T; Shiver JW; Letvin NL J Virol; 2000 Aug; 74(16):7485-95. PubMed ID: 10906202 [TBL] [Abstract][Full Text] [Related]
7. Chimeric adenovirus type 5/35 vector encoding SIV gag and HIV env genes affords protective immunity against the simian/human immunodeficiency virus in monkeys. Someya K; Xin KQ; Ami Y; Izumi Y; Mizuguchi H; Ohta S; Yamamoto N; Honda M; Okuda K Virology; 2007 Oct; 367(2):390-7. PubMed ID: 17628628 [TBL] [Abstract][Full Text] [Related]
8. Vectored Gag and Env but not Tat show efficacy against simian-human immunodeficiency virus 89.6P challenge in Mamu-A*01-negative rhesus monkeys. Liang X; Casimiro DR; Schleif WA; Wang F; Davies ME; Zhang ZQ; Fu TM; Finnefrock AC; Handt L; Citron MP; Heidecker G; Tang A; Chen M; Wilson KA; Gabryelski L; McElhaugh M; Carella A; Moyer C; Huang L; Vitelli S; Patel D; Lin J; Emini EA; Shiver JW J Virol; 2005 Oct; 79(19):12321-31. PubMed ID: 16160159 [TBL] [Abstract][Full Text] [Related]
9. In vivo induction of cellular and humoral immune responses by hybrid DNA vectors encoding simian/human immunodeficiency virus/hepatitis B surface antigen virus particles in BALB/c and HLA-A2-transgenic mice. Marsac D; Puaux AL; Rivière Y; Michel ML Immunobiology; 2005; 210(5):305-19. PubMed ID: 16164038 [TBL] [Abstract][Full Text] [Related]
10. Intravenous inoculation of replication-deficient recombinant vaccinia virus DIs expressing simian immunodeficiency virus gag controls highly pathogenic simian-human immunodeficiency virus in monkeys. Izumi Y; Ami Y; Matsuo K; Someya K; Sata T; Yamamoto N; Honda M J Virol; 2003 Dec; 77(24):13248-56. PubMed ID: 14645581 [TBL] [Abstract][Full Text] [Related]
11. Containment of simian immunodeficiency virus infection in vaccinated macaques: correlation with the magnitude of virus-specific pre- and postchallenge CD4+ and CD8+ T cell responses. Hel Z; Nacsa J; Tryniszewska E; Tsai WP; Parks RW; Montefiori DC; Felber BK; Tartaglia J; Pavlakis GN; Franchini G J Immunol; 2002 Nov; 169(9):4778-87. PubMed ID: 12391187 [TBL] [Abstract][Full Text] [Related]
13. Both mucosal and systemic routes of immunization with the live, attenuated NYVAC/simian immunodeficiency virus SIV(gpe) recombinant vaccine result in gag-specific CD8(+) T-cell responses in mucosal tissues of macaques. Stevceva L; Alvarez X; Lackner AA; Tryniszewska E; Kelsall B; Nacsa J; Tartaglia J; Strober W; Franchini G J Virol; 2002 Nov; 76(22):11659-76. PubMed ID: 12388726 [TBL] [Abstract][Full Text] [Related]
14. Recombinant rubella vectors elicit SIV Gag-specific T cell responses with cytotoxic potential in rhesus macaques. Rosati M; Alicea C; Kulkarni V; Virnik K; Hockenbury M; Sardesai NY; Pavlakis GN; Valentin A; Berkower I; Felber BK Vaccine; 2015 Apr; 33(18):2167-74. PubMed ID: 25802183 [TBL] [Abstract][Full Text] [Related]
15. Therapeutic conserved elements (CE) DNA vaccine induces strong T-cell responses against highly conserved viral sequences during simian-human immunodeficiency virus infection. Munson P; Liu Y; Bratt D; Fuller JT; Hu X; Pavlakis GN; Felber BK; Mullins JI; Fuller DH Hum Vaccin Immunother; 2018 Jul; 14(7):1820-1831. PubMed ID: 29648490 [TBL] [Abstract][Full Text] [Related]
16. CD8 T Cells Show Protection against Highly Pathogenic Simian Immunodeficiency Virus (SIV) after Vaccination with SIV Gene-Expressing BCG Prime and Vaccinia Virus/Sendai Virus Vector Boosts. Kato S; Shida H; Okamura T; Zhang X; Miura T; Mukai T; Inoue M; Shu T; Naruse TK; Kimura A; Yasutomi Y; Matsuo K J Virol; 2021 Jan; 95(4):. PubMed ID: 33087465 [TBL] [Abstract][Full Text] [Related]
17. Immunogenicity of hybrid DNA vaccines expressing hepatitis B core particles carrying human and simian immunodeficiency virus epitopes in mice and rhesus macaques. Fuller DH; Shipley T; Allen TM; Fuller JT; Wu MS; Horton H; Wilson N; Widera G; Watkins DI Virology; 2007 Aug; 364(2):245-55. PubMed ID: 17428516 [TBL] [Abstract][Full Text] [Related]
18. A replication competent adenovirus 5 host range mutant-simian immunodeficiency virus (SIV) recombinant priming/subunit protein boosting vaccine regimen induces broad, persistent SIV-specific cellular immunity to dominant and subdominant epitopes in Mamu-A*01 rhesus macaques. Malkevitch N; Patterson LJ; Aldrich K; Richardson E; Alvord WG; Robert-Guroff M J Immunol; 2003 Apr; 170(8):4281-9. PubMed ID: 12682263 [TBL] [Abstract][Full Text] [Related]
19. Enhanced cellular immune response against SIV Gag induced by immunization with DNA vaccines expressing assembly and release-defective SIV Gag proteins. Bu Z; Ye L; Compans RW; Yang C Virology; 2003 May; 309(2):272-81. PubMed ID: 12758174 [TBL] [Abstract][Full Text] [Related]
20. A noninfectious simian/human immunodeficiency virus DNA vaccine that protects macaques against AIDS. Singh DK; Liu Z; Sheffer D; Mackay GA; Smith M; Dhillon S; Hegde R; Jia F; Adany I; Narayan O J Virol; 2005 Mar; 79(6):3419-28. PubMed ID: 15731236 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]